The potent hepatocarcinogen methapyrilene induces mutations in L5178Y mouse lymphoma cells in the apparent absence of DNA adduct formation
- 1 June 1991
- journal article
- Published by Elsevier in Mutation Research Letters
- Vol. 263 (2) , 127-132
- https://doi.org/10.1016/0165-7992(91)90070-k
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Molecular aspects of chemical mutagenesis in L5178Y/tk+/− mouse lymphoma cellsMutagenesis, 1990
- Classification according to chemical structure, mutagenicity to Salmonella and level of carcinogenicity of a further 42 chemicals tested for carcinogenicity by the U.S. National Toxicology ProgramMutation Research/Genetic Toxicology, 1989
- Specific-locus mutations induced in eukaryotes (especially mammalian cells) by radiation and chemicals: a perspectiveMutation Research/Reviews in Genetic Toxicology, 1989
- The potent hepatocarcinogen methapyrilene does not form DNA adducts in livers of Fischer 344 ratsMutation Research Letters, 1988
- Weak and unexpected mutagenicity to salmonella of the rat hepatocarcinogen methapyrileneEnvironmental Mutagenesis, 1988
- Chromosome analysis of trifluorothymidine‐resistant L5178y mouse lymphoma cell coloniesEnvironmental Mutagenesis, 1986
- Neoplastic conversion in rat liver by the antihistamine methapyrilene demonstrated by a sequential syncarcinogenic effect with N-2-fluorenylacetamideToxicology and Applied Pharmacology, 1984
- A study of the potential genotoxicity of methapyrilene and related antihistamines using the hepatocytes/DNA repair assayMutation Research/Genetic Toxicology, 1984
- Methapyrilene is inactive in the hepatocyte-mediated Chinese hamster ovary/hypoxanthine-guanine phosphoribosyl transferase mutational assayCancer Letters, 1984
- Nitrosation and mutagenicity of some amine drugsToxicology and Applied Pharmacology, 1980